Literature DB >> 2137280

Association of echocardiographic left ventricular mass with body size, blood pressure and physical activity (the Framingham Study).

D D Savage1, D Levy, A L Dannenberg, R J Garrison, W P Castelli.   

Abstract

Left ventricular (LV) hypertrophy has been found to predispose to increased cardiovascular morbidity and mortality. To assess the clinical correlates and potential determinants of LV mass, the relation of echocardiographically determined LV mass to a variety of clinical parameters was examined in a general population. From 1979 to 1983 Framingham Heart Study participants underwent routine evaluation including medical history, physical examination and M-mode echocardiography. LV mass was determined using an anatomically validated formula that incorporates measurements of LV wall thickness and LV internal diameter. The study population consisted of 2,226 men and 2,746 women (mean age 51 years, range 17 to 90). Age, height, systolic blood pressure and body mass index (a measure of obesity) were statistically significant and independent correlates of LV mass in both sexes (p less than 0.001). In men under age 50, leisure-time physical activity was associated with LV mass (p less than 0.05), but this was not observed in women. Results from multivariate analyses in which body mass index and subscapular skinfold thickness were included suggest that lean body mass is correlated with LV mass. Maintenance of ideal body weight and normal blood pressure, weight reduction in obese persons and blood pressure control in hypertensive patients may contribute to the primary and secondary prevention of LV hypertrophy and its sequelae. Clinical interpretation of echocardiograms should include consideration of the correlates of LV mass to gain better insight into the pathogenesis of LV hypertrophy.

Entities:  

Mesh:

Year:  1990        PMID: 2137280     DOI: 10.1016/0002-9149(90)90304-j

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  45 in total

Review 1.  Thyroid hormone and blood pressure regulation.

Authors:  Sara Danzi; Irwin Klein
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

Review 2.  Cardiac remodeling at the population level--risk factors, screening, and outcomes.

Authors:  Ola Gjesdal; David A Bluemke; Joao A Lima
Journal:  Nat Rev Cardiol       Date:  2011-10-25       Impact factor: 32.419

3.  Changes in mid-life fitness predicts heart failure risk at a later age independent of interval development of cardiac and noncardiac risk factors: the Cooper Center Longitudinal Study.

Authors:  Ambarish Pandey; Minesh Patel; Ang Gao; Benjamin L Willis; Sandeep R Das; David Leonard; Mark H Drazner; James A de Lemos; Laura DeFina; Jarett D Berry
Journal:  Am Heart J       Date:  2014-11-12       Impact factor: 4.749

4.  Association of cardiorespiratory fitness with left ventricular remodeling and diastolic function: the Cooper Center Longitudinal Study.

Authors:  Stephanie K Brinker; Ambarish Pandey; Colby R Ayers; Carolyn E Barlow; Laura F DeFina; Benjamin L Willis; Nina B Radford; Ramin Farzaneh-Far; James A de Lemos; Mark H Drazner; Jarett D Berry
Journal:  JACC Heart Fail       Date:  2014-04-30       Impact factor: 12.035

Review 5.  Regression of increased left ventricular mass by antihypertensives.

Authors:  C J Lavie; H O Ventura; F H Messerli
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

6.  Adverse Left Ventricular Remodeling and Age Assessed with Cardiac MR Imaging: The Multi-Ethnic Study of Atherosclerosis.

Authors:  John Eng; Robyn L McClelland; Antoinette S Gomes; W Gregory Hundley; Susan Cheng; Colin O Wu; J Jeffrey Carr; Steven Shea; David A Bluemke; Joao A C Lima
Journal:  Radiology       Date:  2015-10-20       Impact factor: 11.105

Review 7.  Cardiometabolic Disease Leading to Heart Failure: Better Fat and Fit Than Lean and Lazy.

Authors:  Ambarish Pandey; Jarett D Berry; Carl J Lavie
Journal:  Curr Heart Fail Rep       Date:  2015-10

Review 8.  Is Left Ventricular Hypertrophy a Valid Therapeutic Target?

Authors:  Jeremy Earl Brooks; Elsayed Z Soliman; Bharathi Upadhya
Journal:  Curr Hypertens Rep       Date:  2019-05-20       Impact factor: 5.369

Review 9.  Left ventricular hypertrophy. Prevalence in older patients and management.

Authors:  E Paciaroni; A Fraticelli
Journal:  Drugs Aging       Date:  1995-04       Impact factor: 3.923

10.  Cardiac response to exercise in young, normal weight and overweight men and women.

Authors:  Chantal A Vella; Raul Y Zubia; Stephen F Burns; Diana Ontiveros
Journal:  Eur J Appl Physiol       Date:  2008-11-07       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.